Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
257.50    -2.50 (-0.96%)
Bid:
255.00
Ask:
260.00
Spread: 5.00 (1.961%)
Market Cap: £233.92m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Launch

24 Oct 2013 16:13

RNS Number : 3552R
Concurrent Technologies PLC
24 October 2013
 



24 October 2013

Concurrent Technologies Plc

 

Product Launch

VPX product range extension

 

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products for critical applications in the defence, aerospace, telecommunications, transportation, scientific and industrial markets, is pleased to announce further product additions to its range of VPX products for both commercial and harsh environments.

 

The TR B11/msd is a 3U VPX board featuring either the Intel® Core™ i5-4402E or the Intel® Core™ i5-4400E dual core processors. With up to 16 Gbytes of DRAM and a rich assortment of I/O interfaces, this board is an ideal processor board for 3U VPX solutions requiring the latest in processing performance, but requiring less power than the quad-core variant, thereby extending the range of potential applications for this product line. 3U VPX is particularly well suited to high-end compute intensive applications in military embedded, aerospace and transportation systems for data acquisition, control systems and video signal processing. Ruggedised variants of dual and quad-core variants will be released in early 2014 to meet the demands of applications within harsher environments.

 

Also released and in production to existing customers are the ruggedised versions of the TR 90x/x1x single board computer. Announced last year as commercial products, the TR 90x/x1x features dual-core or quad-core 3rd generation Intel® Core™ i7 processors and Mobile Intel® QM77 Express chipset with up to 16 Gbytes of ECC DRAM.

 

Glen Fawcett, Managing Director, Concurrent Technologies Plc, commented:

 

"The release of these new product variants provides our customers with a wider choice of performance to power ratio options, depending upon their application. Their investment in their application software can be reutilised across different applications and environments by choosing the most appropriate variant of our products. The TR B11/msd and the TR 90x/x1x are part of a continuing product line aimed at a wide range of applications while providing enhanced ongoing product life cycle which is essential for customers in our defence markets in particular."

 

Enquiries:

Concurrent Technologies PlcGlen Fawcett, Managing Director

 

+44 (0)1206 752 626

Newgate Threadneedle (Financial PR)Caroline Evans-Jones

Robyn McConnachie

+44 (0)207 653 9850

Cenkos Securities plc (NOMAD)Ken FlemingNeil McDonald

+44 (0)131 220 6939+44 (0)131 220 9771

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using Intel® processors, including the latest 4th generation Intel® Core™ i7, 3rd generation Intel® Core™ i7, 2nd generation Intel® Core™ i7, Intel® Core™ i7 processors, Intel® Xeon® and Atom™ processors, the Company offers a wide range of computer products which are designed to be compliant with industry specifications including those for products used in extremely harsh environments.

 

For more information on Concurrent Technologies Plc and its products please visit www.cct.co.uk.

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLMIBATMBMTBFJ
Date   Source Headline
19th Mar 201412:36 pmRNSNotice of Results
17th Feb 20144:18 pmRNSHolding(s) in Company
27th Dec 20137:00 amRNSTrading Update
13th Dec 20134:31 pmRNSProduct Launch
6th Dec 20131:35 pmRNSHolding(s) in Company
28th Nov 201311:31 amRNSHolding(s) in Company
1st Nov 20133:45 pmRNSTotal Voting Rights
24th Oct 20134:13 pmRNSProduct Launch
23rd Oct 20132:56 pmRNSTransaction in Own Shares
8th Oct 20132:35 pmRNSProduct Launch
4th Oct 20135:01 pmRNSTransaction in Own Shares
1st Oct 20133:13 pmRNSTotal Voting Rights
25th Sep 20132:38 pmRNSTransaction in Own Shares
4th Sep 20132:42 pmRNSTransaction in Own Shares
22nd Aug 20137:00 amRNSInterim Results
16th Aug 20133:58 pmRNSNotice of Results
12th Aug 201312:40 pmRNSTrading Update
21st Jun 201312:20 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSProduct Launch
28th May 20132:00 pmRNSAGM Statement
24th May 20133:10 pmRNSProduct Launch
13th May 20134:25 pmRNSProduct Launch
24th Apr 20135:01 pmRNSDistribution of Annual Report and Accounts
9th Apr 20137:00 amRNSFinal Results
19th Mar 20134:25 pmRNSNotice of Results & Dividend
1st Mar 20132:15 pmRNSProduct Launch
24th Dec 20127:00 amRNSTrading Update
21st Dec 20121:17 pmRNSProduct Launch
21st Nov 20123:27 pmRNSHolding(s) in Company
5th Nov 201212:25 pmRNSProduct Launch
31st Oct 201210:32 amRNSTotal Voting Rights
19th Sep 20125:28 pmRNSHolding(s) in Company
5th Sep 20127:00 amRNSInterim Results
29th Aug 20125:36 pmRNSNotice of Results
22nd Jun 20124:42 pmRNSTotal Voting Rights
14th Jun 20123:50 pmRNSTransaction in Own Shares
7th Jun 20127:00 amRNSProduct Launch
31st May 20123:30 pmRNSTotal Voting Rights
29th May 20121:30 pmRNSAGM Statement
22nd May 201212:21 pmRNSTreasury Shares
8th May 20127:00 amRNSDistribution of Annual Report and Accounts
4th May 20123:53 pmRNSHolding(s) in Company
17th Apr 20123:51 pmRNSHolding(s) in Company
12th Apr 201211:44 amRNSHolding(s) in Company
26th Mar 20127:00 amRNSPreliminary Results
16th Mar 20123:17 pmRNSNotice of Results
6th Mar 20121:45 pmRNSDividend Declaration
16th Jan 20127:00 amRNSProduct Launch
29th Dec 20115:46 pmRNSDirector/PDMR Shareholding
22nd Dec 201112:41 pmRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.